Suchergebnis | Hamburg Open Science

Facetten

15 Einträge gefunden

Cadherin-11 mRNA- und Protein-Expression in Ovarialtumoren unterschiedlicher Malignität: kein Hinweis auf eine onkogene oder tumorsupprimierende Funktion., Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function.
2015 - Forschungsinformationssystem des UKE
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin
2011 - Forschungsinformationssystem des UKE
Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
2009 - Forschungsinformationssystem des UKE
Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
2009 - Forschungsinformationssystem des UKE
Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
2008 - Forschungsinformationssystem des UKE
Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer.
2007 - Forschungsinformationssystem des UKE
Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
2006 - Forschungsinformationssystem des UKE
The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
2004 - Forschungsinformationssystem des UKE
Expression pattern of the activating protein-1 family of transcription factors in the human placenta.
2004 - Forschungsinformationssystem des UKE
Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta.
2004 - Forschungsinformationssystem des UKE
Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer.
2003 - Forschungsinformationssystem des UKE
FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.
2003 - Forschungsinformationssystem des UKE
Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
2003 - Forschungsinformationssystem des UKE
Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.
2003 - Forschungsinformationssystem des UKE
Expression of the adhesion molecule CEACAM1 (CD66a, BGP, C-CAM) in breast cancer is associated with the expression of the tumor-suppressor genes Rb, Rb2, and p27.
2002 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Cadherin-11 mRNA- und Protein-Expression in Ovarialtumoren unterschiedlicher Malignität: kein Hinweis auf eine onkogene oder tumorsupprimierende Funktion., Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function.

Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin

Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.

Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.

Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer.

Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.

The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.

Expression pattern of the activating protein-1 family of transcription factors in the human placenta.

Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta.

Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer.

FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.

Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.

Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.

Expression of the adhesion molecule CEACAM1 (CD66a, BGP, C-CAM) in breast cancer is associated with the expression of the tumor-suppressor genes Rb, Rb2, and p27.